International Immunology Advance Access published online on November 29, 2004
International Immunology, doi:10.1093/intimm/dxh192
© 2004 by The Japanese Society for Immunology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Clinical Immunology, Department of Laboratory Medicine, F79, Karolinska University Hospital Huddinge, Karolinska Institute, SE-141 86, Stockholm, Sweden
* To whom correspondence should be addressed. The mechanism underlying selective IgG subclass deficiency is largely unknown in humans. We have previously reported the acquisition of a complete IgG2 deficiency in a leukemia patient after bone marrow transplantation. Southern blot analysis showed a deletion including the C
Accepted October 29, 2004
Article
Selective IgG2 deficiency due to a point mutation causing abnormal splicing of the C
2 gene
Yaofeng Zhao, E-mail: Yaofeng.Zhao{at}labmed.ki.se
![]()
Abstract
2 and C
4 genes on one chromosome in the donor, suggesting that the remaining C
2 gene allele was silent. In the patient and his two IgG2 deficient brothers, the silent C
2 gene showed both germ-line transcription and switch recombination and no structural defects were found in the intronic promoter or the switch region of the gene. However, an A
G transition in the fourth nucleotide in the 5' portion of intron 1 was identified. Transfection of artificial constructs into the human B cell lines demonstrated that this A
G transition inactivated the normal splice site, and instead, a cryptic splice site in the CH1 exon was used in RNA post-transcriptional processing, leading to a 16 bp deletion of the
2 CH1 exon. This aberrantly spliced RNA that is mostly derived from germ-line transcription in vivo was also detected in both homozygous and heterozygous individuals carrying this mutation. These findings suggest a novel genetic mechanism as the cause of IgG subclass deficiency in selected patients.![]()
CiteULike
Connotea
Del.icio.us What's this?